Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H, Wu J, Yuan J, Li H, Zhang Y, Wu W, Chen W, Wang C, Meng S, Chen S, Huo M, He Y, Zhang C. Zhang H, et al. Among authors: chen s, chen w. J Exp Clin Cancer Res. 2021 Aug 19;40(1):260. doi: 10.1186/s13046-021-02052-z. J Exp Clin Cancer Res. 2021. Retraction in: J Exp Clin Cancer Res. 2022 Feb 15;41(1):63. doi: 10.1186/s13046-022-02268-7 PMID: 34412665 Free PMC article. Retracted.
Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H, Wu J, Yuan J, Li H, Zhang Y, Wu W, Chen W, Wang C, Meng S, Chen S, Huo M, He Y, Zhang C. Zhang H, et al. Among authors: chen s, chen w. J Exp Clin Cancer Res. 2022 Feb 15;41(1):63. doi: 10.1186/s13046-022-02268-7. J Exp Clin Cancer Res. 2022. PMID: 35168643 Free PMC article. No abstract available.
87,194 results
You have reached the last available page of results. Please see the User Guide for more information.